Swedish Luxury Stock News

The board of Telia Company AB (publ) ( STO:TELIA ) has announced that it will pay a dividend on the 11th of February...

In the last year, multiple insiders have substantially increased their holdings of Alleima AB (publ) ( STO:ALLEI...

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Key Insights The considerable ownership by private companies in Fastighets AB Balder indicates that they collectively...

The European market has shown resilience, with the STOXX Europe 600 Index gaining ground thanks to robust economic data and encouraging earnings results. Amid this backdrop, penny stocks—though often associated with speculative trading—remain a relevant investment area when backed by solid financials. These smaller or newer companies can offer a unique blend of affordability and growth potential, making them attractive options for investors seeking opportunities beyond the mainstream.

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Cheffelo's (STO:CHEF) stock is up by a considerable 24% over the past month. As most would know, fundamentals are what...

With a price-to-earnings (or "P/E") ratio of 62.5x Haypp Group AB (publ) ( STO:HAYPP ) may be sending very bearish...

The recent 10% drop in Candles Scandinavia AB (publ)'s ( STO:CANDLE B ) stock could come as a blow to insiders who...

While Arjo AB (publ) ( STO:ARJO B ) might not have the largest market cap around , it saw its share price hover around...

It hasn't been the best quarter for Metacon AB (publ) ( STO:META ) shareholders, since the share price has fallen 26...

Key Insights Significant control over Volati by individual investors implies that the general public has more power to...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Invisio fair value estimate is kr403 Invisio's kr313 share...

Key Insights The projected fair value for Starbreeze is kr0.12 based on 2 Stage Free Cash Flow to Equity Current share...

Key Insights Given the large stake in the stock by institutions, Bufab's stock price might be vulnerable to their...

Key Insights Lifco's significant insider ownership suggests inherent interests in company's expansion The largest...

To the annoyance of some shareholders, Acuvi AB ( STO:ACUVI ) shares are down a considerable 26% in the last month...

Gruvaktiebolaget Viscaria ( STO:VISC ) shareholders are no doubt pleased to see that the share price has bounced 41% in...

There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...

Camurus AB (publ) recently announced that the U.S. FDA has accepted for review its resubmitted New Drug Application for Oclaiz (CAM2029), an extended-release octreotide injection for acromegaly, with a PDUFA target action date set for 10 June 2026. This acceptance helps clear a prior hurdle tied to third-party manufacturing observations and follows earlier EU and UK approvals and launch of the same product, marketed there as Oczyesa. We will now examine how FDA acceptance of the Oclaiz...